Clinical Trial Results

Showing: All studies [change]
Condition: Cancer Location: Sacramento, California 25 trials found
New Search
Filter
Trial Phase
Study Type
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
PHASE3INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Studying Tumor Tissue Samples and Blood Samples to Learn More About DNA Changes in Patients With Lung Cancer
N/AOBSERVATIONAL Sacramento, California
RECRUITING
Collection of Tissue Samples for Cancer Research
N/AOBSERVATIONAL Sacramento, California +4 more
RECRUITING
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
NAINTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
PHASE3INTERVENTIONAL Loma Linda, California +4 more
RECRUITING
Project: Every Child for Younger Patients With Cancer
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
PHASE2INTERVENTIONAL Orange, California +4 more
RECRUITING
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
PHASE3INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
NAINTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer
NAINTERVENTIONAL La Jolla, California +2 more
RECRUITING
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
PHASE1INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
PHASE2, PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
PHASE1, PHASE2INTERVENTIONAL Duarte, California +4 more
RECRUITING
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
PHASE3INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
PHASE3INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
PHASE2INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
NAINTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
PHASE3INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
PHASE2INTERVENTIONAL Duarte, California +4 more
RECRUITING
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
PHASE2, PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Patient-Derived Xenografts to Reduce Cancer Health Disparities
N/AOBSERVATIONAL Orange, California +1 more
RECRUITING
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
PHASE2INTERVENTIONAL Sacramento, California +4 more
RECRUITING
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
PHASE1INTERVENTIONAL La Jolla, California +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type